Recent changes in cancer care in India show an increase in immunotherapy prescriptions due to affordable biosimilars. Doctors report that the availability of cheaper versions of nivolumab has improved patient access to treatment. Research indicates that lower doses may be effective for Indian patients, contributing to the affordability of therapy. Although progress has been made, significant challenges remain regarding drug availability and hospital practices.
Related Posts
Walking a tightrope: 5 hurdles facing Noel Tata and an unlisted Tata Sons
Noel Tata’s plan for merging Tata companies seeks to maintain the private status of Tata Sons, avoiding any public listing.…
‘She planned it, no he forced me’: Twist in Pune realtor murder; Siya & Chetan turn on each other
A shocking murder case involving realtor Ketan Agarwal has taken a dramatic turn as his fiancée, Siya Goyal, and her…